These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15686921)

  • 1. Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13).
    Kim SH; Pudzianowski AT; Leavitt KJ; Barbosa J; McDonnell PA; Metzler WJ; Rankin BM; Liu R; Vaccaro W; Pitts W
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1101-6. PubMed ID: 15686921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.
    Hu Y; Xiang JS; DiGrandi MJ; Du X; Ipek M; Laakso LM; Li J; Li W; Rush TS; Schmid J; Skotnicki JS; Tam S; Thomason JR; Wang Q; Levin JI
    Bioorg Med Chem; 2005 Dec; 13(24):6629-44. PubMed ID: 16216515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.
    Nicolotti O; Catto M; Giangreco I; Barletta M; Leonetti F; Stefanachi A; Pisani L; Cellamare S; Tortorella P; Loiodice F; Carotti A
    Eur J Med Chem; 2012 Dec; 58():368-76. PubMed ID: 23149299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold.
    Lepifre F; Christmann-Franck S; Roche D; Leriche C; Carniato D; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3682-5. PubMed ID: 19450980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
    Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.
    Szardenings AK; Harris D; Lam S; Shi L; Tien D; Wang Y; Patel DV; Navre M; Campbell DA
    J Med Chem; 1998 Jun; 41(13):2194-200. PubMed ID: 9632351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.
    Blagg JA; Noe MC; Wolf-Gouveia LA; Reiter LA; Laird ER; Chang SP; Danley DE; Downs JT; Elliott NC; Eskra JD; Griffiths RJ; Hardink JR; Haugeto AI; Jones CS; Liras JL; Lopresti-Morrow LL; Mitchell PG; Pandit J; Robinson RP; Subramanyam C; Vaughn-Bowser ML; Yocum SA
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1807-10. PubMed ID: 15780611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potent and selective MMP-13 inhibitors.
    Wu J; Rush TS; Hotchandani R; Du X; Geck M; Collins E; Xu ZB; Skotnicki J; Levin JI; Lovering FE
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4105-9. PubMed ID: 16005220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-substituted homopiperazine barbiturates as gelatinase inhibitors.
    Wang J; Medina C; Radomski MW; Gilmer JF
    Bioorg Med Chem; 2011 Aug; 19(16):4985-99. PubMed ID: 21764590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocyclic amino carboxylates as selective MMP-8 inhibitors.
    Cherney RJ; Wang L; Meyer DT; Xue CB; Wasserman ZR; Hardman KD; Welch PK; Covington MB; Copeland RA; Arner EC; DeGrado WF; Decicco CP
    J Med Chem; 1998 May; 41(11):1749-51. PubMed ID: 9599226
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines.
    Szardenings AK; Antonenko V; Campbell DA; DeFrancisco N; Ida S; Shi L; Sharkov N; Tien D; Wang Y; Navre M
    J Med Chem; 1999 Apr; 42(8):1348-57. PubMed ID: 10212120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model.
    Tsuchida K; Chaki H; Takakura T; Kotsubo H; Tanaka T; Aikawa Y; Shiozawa S; Hirono S
    J Med Chem; 2006 Jan; 49(1):80-91. PubMed ID: 16392794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
    Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13.
    Freeman-Cook KD; Reiter LA; Noe MC; Antipas AS; Danley DE; Datta K; Downs JT; Eisenbeis S; Eskra JD; Garmene DJ; Greer EM; Griffiths RJ; Guzman R; Hardink JR; Janat F; Jones CS; Martinelli GJ; Mitchell PG; Laird ER; Liras JL; Lopresti-Morrow LL; Pandit J; Reilly UD; Robertson D; Vaughn-Bowser ML; Wolf-Gouviea LA; Yocum SA
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6529-34. PubMed ID: 17935984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
    Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.
    Brandstetter H; Engh RA; Von Roedern EG; Moroder L; Huber R; Bode W; Grams F
    Protein Sci; 1998 Jun; 7(6):1303-9. PubMed ID: 9655333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).
    Graf von Roedern E; Grams F; Brandstetter H; Moroder L
    J Med Chem; 1998 Jan; 41(3):339-45. PubMed ID: 9464365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.